Skip to main content

Peer Review reports

From: Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)

Original Submission
30 Sep 2020 Submitted Original manuscript
7 Dec 2020 Author responded Author comments - Keisuke Miwa
3 Nov 2020 Reviewed Reviewer Report - Ali I Shamseddine
6 Nov 2020 Reviewed Reviewer Report
Resubmission - Version 2
7 Dec 2020 Submitted Manuscript version 2
21 Dec 2020 Author responded Author comments - Keisuke Miwa
20 Dec 2020 Reviewed Reviewer Report - Ali I Shamseddine
8 Dec 2020 Reviewed Reviewer Report
Resubmission - Version 3
21 Dec 2020 Submitted Manuscript version 3
Publishing
23 Dec 2020 Editorially accepted
5 Jan 2021 Article published 10.1186/s12885-020-07766-5

You can find further information about peer review here.

Back to article page